HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma.

Abstract
Effective strategies for hepatocellular carcinoma, which is the second leading cause of death worldwide, remain limited. A growing body of emerging evidence suggests that ferroptosis activation is a novel promising approach for the treatment of this malignancy. Nevertheless, the potential therapeutic targets and molecular mechanisms of ferroptosis remain elusive. In this study, we found that PNO1 is a bona fide inhibitor of ferroptosis and that autophagy induced by PNO1 promotes cystine/glutamate antiporter SLC7A11 while increasing the synthesis and accumulation of intracellular glutamate. This increase is followed by an equally proportional addition in cystine uptake, which consequently enhances system Xc- activity that leads to the inhibition of ferroptosis. In the maintenance of redox homeostasis, system Xc- activated via PNO1-autophagy metabolism is responsible for maintaining cysteine for glutathione (GSH) synthesis, and the final GSH metabolic reprogramming protects HCC cells from ferroptosis. The combination of PNO1 inhibition with drugs causing ferroptosis induction, particularly sorafenib, the first-line drug associated with ferroptosis in liver cancer shows therapeutic promise in vitro and in vivo. Together, our findings indicated that PNO1 protects HCC cells from ferroptotic death through autophagy-mediated GSH metabolic remodeling, and we identified a candidate therapeutic target that may potentiate the effect of ferroptosis-based antitumor therapy.
AuthorsXiaomeng Hu, Yuchao He, Zhiqiang Han, Wei Liu, Dongming Liu, Xihao Zhang, Lu Chen, Lisha Qi, Liwei Chen, Yi Luo, Qiang Li, Peng Chen, Qiang Wu, Xiaolin Zhu, Hua Guo
JournalCell death & disease (Cell Death Dis) Vol. 13 Issue 11 Pg. 1010 (11 29 2022) ISSN: 2041-4889 [Electronic] England
PMID36446769 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s).
Chemical References
  • Cystine
  • Glutamic Acid
  • Glutathione
  • PNO1 protein, human
  • RNA-Binding Proteins
Topics
  • Humans
  • Autophagy (genetics)
  • Carcinoma, Hepatocellular (genetics, metabolism)
  • Cystine
  • Ferroptosis (genetics)
  • Glutamic Acid
  • Glutathione
  • Liver Neoplasms (genetics, metabolism)
  • RNA-Binding Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: